Searched for
BIOLOGICS AND RADIOPHARMACEUTICAL DRUGS
Aurobindo Pharma arm CuraTeQ gets Health Canada nod for biosimilarAurobindo Pharma announced a significant development today. Its subsidiary, CuraTeQ Biologics, has received a compliance notice from Health...- Aurobindo Pharma’s Dyrupeg faces Health Canada compliance noticeCuraTeQ Biologics, a part of Aurobindo Pharma, has secured a crucial approval from Health Canada for its biosimilar drug Dyrupeg. This medi...
- As headwinds slow & managements become realistic, time for a relook: 5 mid-cap pharma stocks with upside potential of up to 44%Every sector goes through a phase when managements become over-optimistic, taking decisions that should have been avoided. But then, with t...
- Pharma sector: Look beyond the tariff reprieve for generics. 6 mid-cap pharma stocks with an upside potential of more than 23%With US President Trump, nothing can be ruled out. But, for now at least, Indian pharma companies can breathe a little easier. The 100% tar...
- Looking at mid-caps? Keep your portfolio healthy: 5 mid-cap pharma stocks with an upside potential of up to 38%Even as the bears are running wild on the street causing across-the-board damage, there are sectors that have kept them at bay. And that’s ...
- Stock picks of the week: 4 stocks with consistent score improvement and upside potential of up to 37%Friday's movement of the Nifty and Sensex will make a number of people think again about volatility. While Friday ’s decline can be attribu...
Load More